Tissue proteomics for cancer biomarker development: laser microdissection and 2D-DIGE.
about
Mass spectrometric characterization of protein structure details refines the proteome signature for invasive ductal breast carcinoma.Towards a proteome signature for invasive ductal breast carcinoma derived from label-free nanoscale LC-MS protein expression profiling of tumorous and glandular tissue.Proteomic analysis of pancreatic intraepithelial neoplasia and pancreatic carcinoma in rat modelsProtein analysis through Western blot of cells excised individually from human brain and muscle tissueN-linked glycoproteomic analysis of formalin-fixed and paraffin-embedded tissuesHeterogeneous nuclear ribonucleoprotein K (hnRNP K) is a tissue biomarker for detection of early hepatocellular carcinoma in patients with cirrhosis.Identification and validation of potential new biomarkers for prostate cancer diagnosis and prognosis using 2D-DIGE and MS.Identification and Characterization of Cell Wall Proteins of a Toxic Dinoflagellate Alexandrium catenella Using 2-D DIGE and MALDI TOF-TOF Mass Spectrometry.Discovery and validation of graft-versus-host disease biomarkersMass spectrometry-based label-free quantitative proteomics.Challenges in cancer research and multifaceted approaches for cancer biomarker quest.Current advances in tumor proteomics and candidate biomarkers for hepatic cancer.Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer.Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.Proteomic analysis of tissue samples in translational breast cancer research.Omic approaches in environmental issues.Establishment of combined analytical method to extract the genes of interest from transcriptome data.
P2860
Q30401624-E290D39D-CA17-4343-9480-3F7A1F1406DEQ33513987-E2DD4C52-AC5D-463F-98CC-8FA57EB7EA99Q33864628-59E9C2F7-0F6F-4C14-AB73-5E7D824294B7Q34188823-4ADA6BC6-3352-4140-85C2-DC07F49E1CADQ34287959-8B140CB9-808B-4F4E-A3FE-5AEC39E64041Q34325161-2929F87A-7EA8-480A-B5D0-2CDC268F070EQ35033878-C12F569C-57FE-4AE9-AA59-899C9FC901EDQ35196855-9323C499-95EE-4818-AA5B-BF1E768E4592Q36569667-B3B0689B-6698-4E74-9194-6840E7B02D78Q37416474-5CEDC355-DA14-4403-A93E-D11BED75D232Q37425361-FE0768AA-D775-406D-859C-B51D6625DC50Q37610317-58828CE3-C05F-4D65-9800-6FEE8DBFACA8Q37728847-3E034128-17BA-4E99-B660-C6EB54405634Q37800056-07042A20-FF13-46B1-AC57-A6E20F8C5D01Q38212502-3DC42B48-A317-4DA9-9D13-BCBE5C7B5D17Q38858389-D9B71E01-8568-4A10-8CC4-3AC45E78211FQ41683007-6ACD1F11-D8BF-4291-8676-4CCE11F1CC62
P2860
Tissue proteomics for cancer biomarker development: laser microdissection and 2D-DIGE.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Tissue proteomics for cancer biomarker development: laser microdissection and 2D-DIGE.
@ast
Tissue proteomics for cancer biomarker development: laser microdissection and 2D-DIGE.
@en
type
label
Tissue proteomics for cancer biomarker development: laser microdissection and 2D-DIGE.
@ast
Tissue proteomics for cancer biomarker development: laser microdissection and 2D-DIGE.
@en
prefLabel
Tissue proteomics for cancer biomarker development: laser microdissection and 2D-DIGE.
@ast
Tissue proteomics for cancer biomarker development: laser microdissection and 2D-DIGE.
@en
P1433
P1476
Tissue proteomics for cancer biomarker development: laser microdissection and 2D-DIGE.
@en
P2093
Tadashi Kondo
P304
P356
10.5483/BMBREP.2008.41.9.626
P577
2008-09-01T00:00:00Z